BDNF and early-onset autosomal dominant Alzheimer disease: In contrast, in a mouse model of Alzheimer’s disease, a 2-fold increase in endogenous BDNF caused by the reduction of microRNA (miR)-206, a direct negative regulator of BDNF levels, alleviates the disease phenotype [17].